Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.7%
5Y CAGR+16.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+8.7%/yr
vs +21.2%/yr prior
5Y CAGR
+16.9%/yr
Recent deceleration
Acceleration
-12.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $202.92M | +11.7% |
| 2024 | $181.59M | +18.2% |
| 2023 | $153.65M | -2.7% |
| 2022 | $157.95M | +3.1% |
| 2021 | $153.20M | +64.5% |
| 2020 | $93.14M | +15.3% |
| 2019 | $80.75M | +10.3% |
| 2018 | $73.19M | +26.3% |
| 2017 | $57.96M | +77.4% |
| 2016 | $32.67M | - |